KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Inventory Average (2016 - 2026)

Neogenomics filings provide 16 years of Inventory Average readings, the most recent being $29.2 million for Q1 2026.

  • On a quarterly basis, Inventory Average rose 3.33% to $29.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.2 million, a 3.33% increase, with the full-year FY2025 number at $27.7 million, up 8.66% from a year prior.
  • Inventory Average hit $29.2 million in Q1 2026 for Neogenomics, up from $28.5 million in the prior quarter.
  • In the past five years, Inventory Average ranged from a high of $32.0 million in Q2 2025 to a low of $21.8 million in Q2 2024.
  • Median Inventory Average over the past 5 years was $24.4 million (2023), compared with a mean of $25.5 million.
  • Biggest five-year swings in Inventory Average: fell 11.83% in 2024 and later skyrocketed 46.88% in 2025.
  • Neogenomics' Inventory Average stood at $24.0 million in 2022, then rose by 0.28% to $24.1 million in 2023, then grew by 6.21% to $25.6 million in 2024, then grew by 11.37% to $28.5 million in 2025, then rose by 2.41% to $29.2 million in 2026.
  • The last three reported values for Inventory Average were $29.2 million (Q1 2026), $28.5 million (Q4 2025), and $31.3 million (Q3 2025) per Business Quant data.